HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Nakagawa Selected Research

Melanoma (Melanoma, Malignant)

1/2006Histone deacetylase inhibitor FK228 suppresses the Ras-MAP kinase signaling pathway by upregulating Rap1 and induces apoptosis in malignant melanoma.
10/2001Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
10/2001Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: successful treatment of oral melanoma and distant skin lesion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Nakagawa Research Topics

Disease

37Neoplasms (Cancer)
11/2017 - 01/2000
8Psoriasis (Pustulosis Palmaris et Plantaris)
03/2017 - 05/2001
8Inflammation (Inflammations)
04/2011 - 06/2000
7Infections
10/2015 - 11/2000
6Atopic Dermatitis (Atopic Eczema)
01/2018 - 05/2001
6Breast Neoplasms (Breast Cancer)
02/2007 - 02/2000
5Hypertension (High Blood Pressure)
09/2015 - 02/2002
5Asthma (Bronchial Asthma)
08/2001 - 01/2000
5Glioma (Gliomas)
06/2001 - 01/2000
4Wounds and Injuries (Trauma)
10/2014 - 06/2001
4Carcinoma (Carcinomatosis)
12/2011 - 02/2000
4Hyperplasia
04/2007 - 06/2000
4Neoplasm Metastasis (Metastasis)
10/2001 - 01/2000
4Hypersensitivity (Allergy)
08/2001 - 01/2000
3Pruritus (Itching)
01/2018 - 06/2003
3Esophageal Neoplasms (Esophageal Cancer)
10/2015 - 05/2000
3Colorectal Neoplasms (Colorectal Cancer)
10/2015 - 01/2001
3Body Weight (Weight, Body)
10/2008 - 02/2000
3Melanoma (Melanoma, Malignant)
01/2006 - 10/2001
3Pain (Aches)
08/2005 - 06/2001
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2001 - 08/2000
2Obesity
03/2024 - 12/2012
2Hepatocellular Carcinoma (Hepatoma)
11/2017 - 01/2000
2Hemorrhage
10/2014 - 04/2011
2Atherosclerosis
07/2013 - 09/2005
2Thrombosis (Thrombus)
07/2013 - 11/2002
2Hypercholesterolemia
12/2012 - 06/2000
2Adenocarcinoma
01/2008 - 05/2001
2Leukemia
11/2007 - 09/2000
2Cardiovascular Diseases (Cardiovascular Disease)
01/2007 - 08/2000
2Coronary Disease (Coronary Heart Disease)
01/2007 - 09/2003
2Tachycardia (Tachyarrhythmias)
10/2002 - 02/2001
2Birth Weight (Birth Weights)
06/2002 - 04/2001
2Spinal Cord Diseases
11/2001 - 06/2001
2Carcinogenesis
11/2001 - 01/2000
2Skin Diseases (Skin Disease)
05/2001 - 01/2001
2Necrosis
04/2001 - 01/2000
2Aneurysm (Aneurysms)
01/2001 - 07/2000
2Conjunctivitis
01/2001 - 08/2000
2Hydrocephalus (Hydrocephaly)
01/2001 - 10/2000
2Aspirin-Induced Asthma
12/2000 - 01/2000
2Hodgkin Disease (Hodgkin's Disease)
12/2000 - 08/2000
2Multiple Myeloma
12/2000 - 08/2000

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
08/2013 - 01/2000
6CytokinesIBA
02/2016 - 11/2000
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2014 - 01/2000
4CholesterolIBA
12/2012 - 04/2001
4Anti-Bacterial Agents (Antibiotics)IBA
04/2011 - 06/2000
4Complementary DNA (cDNA)IBA
01/2011 - 07/2001
4AntigensIBA
01/2011 - 08/2000
4EnzymesIBA
09/2010 - 03/2000
4Antineoplastic Agents (Antineoplastics)IBA
01/2006 - 03/2000
4Indicators and Reagents (Reagents)IBA
10/2001 - 03/2001
4Estrogen ReceptorsIBA
06/2001 - 08/2000
3InterleukinsIBA
03/2017 - 10/2001
3CollagenIBA
02/2007 - 03/2001
3LipidsIBA
01/2007 - 06/2000
3Messenger RNA (mRNA)IBA
01/2006 - 03/2000
3beta CateninIBA
10/2001 - 01/2000
3Chemotactic FactorsIBA
10/2001 - 11/2000
3Fibrinogen (Factor I)FDA Link
08/2001 - 03/2000
3Dipyrone (Metamizole)IBA
08/2001 - 01/2000
3Methacholine Chloride (Methacholine)FDA Link
07/2000 - 01/2000
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2017 - 04/2007
2brodalumabIBA
03/2017 - 11/2016
2Biomarkers (Surrogate Marker)IBA
03/2016 - 07/2001
2Immunoglobulin G (IgG)IBA
10/2015 - 01/2001
2Interleukin-12 (IL 12)IBA
10/2015 - 10/2001
2Monoclonal AntibodiesIBA
10/2015 - 06/2015
2Interleukin-6 (Interleukin 6)IBA
09/2015 - 06/2001
2CreatinineIBA
12/2012 - 05/2004
2AntibodiesIBA
04/2011 - 01/2009
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2011 - 06/2003
2Peptides (Polypeptides)IBA
01/2011 - 09/2000
2DNA (Deoxyribonucleic Acid)IBA
08/2010 - 07/2001
2SteroidsIBA
01/2009 - 07/2000
2Histone Deacetylase InhibitorsIBA
11/2007 - 01/2006
2ErbB Receptors (EGF Receptor)IBA
04/2007 - 10/2000
2Phosphotransferases (Kinase)IBA
01/2006 - 07/2001
2Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2004 - 07/2000
2NimustineIBA
01/2003 - 03/2000
2CalciumIBA
12/2002 - 02/2002
2Coloring Agents (Dyes)IBA
11/2001 - 03/2000
2Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
10/2001 - 04/2001
2LipopolysaccharidesIBA
10/2001 - 04/2000
2thiocyanateIBA
09/2001 - 07/2001
2Bronchodilator Agents (Bronchodilators)IBA
08/2001 - 01/2000
2Ethanol (Ethyl Alcohol)IBA
07/2001 - 01/2000
2Eicosapentaenoic AcidIBA
06/2001 - 08/2000
2Hormones (Hormone)IBA
06/2001 - 04/2001
2Linoleic Acid (Linoleate)IBA
06/2001 - 04/2001
2Carboplatin (JM8)FDA LinkGeneric
03/2001 - 12/2000
2Analgesics (Analgesic Drugs)IBA
01/2001 - 01/2000

Therapy/Procedure

16Therapeutics
03/2024 - 01/2000
9Drug Therapy (Chemotherapy)
12/2011 - 03/2000
3Immunotherapy
12/2011 - 10/2001
3Radiotherapy
08/2010 - 09/2000
2Decompression
11/2001 - 06/2001
2Craniotomy
07/2001 - 06/2001
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2000 - 08/2000